Oral streptogramins in the management of patients with methicillin-resistant Straphylococcus aureus (MRSA) infections

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 3, 2003, Pages 731-735

  Dancer, Stephanie J ^a   Robb, A ^a   Crawford, A ^a   Morrison, D ^b  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

Author keywords

MRSA infections; Oral streptogramins

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; GENTAMICIN; HEXACHLOROPHENE; LINEZOLID; MACROLIDE; MIKAMYCIN B; POLYMYXIN B; PRISTINAMYCIN; PSEUDOMONIC ACID; RIFAMPICIN; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE; TRICLOSAN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; RASH; SKIN; SOFT TISSUE; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BACTERIOPHAGE TYPING; CHRONIC DISEASE; CONFIDENCE INTERVALS; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOGRAMINS;

EID: 0037340695     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg143     Document Type: Article

References (10)

1. Pechere, J. C. (1997). Streptogramins. In Antibiotic and Chemotherapy: Anti-Infective Agents and Their Use in Therapy, 7th edn (O'Grady, F., Finch, R. G., Lambert, H. P. & Greenwood, D., Eds), pp. 416-8. Churchill Livingstone, Edinburgh, UK.
2. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. (1997). Evaluating treatment protocols to prevent antibiotic resistance. Proceedings of the National Academy of Sciences, USA 94, 12106-11.
3. Working party report. (1993). National prevalence survey of hospital acquired infections: definitions. Journal of Hospital Infection 24, 69-76.
4. Cutting, K. F. & Harding, K. G. (1994). Criteria for identifying wound infection. Journal of Wound Care 3, 198-201.
5. Moellering, R. C., Linden, P. K., Reinhardt, J., Blumberg, E. A., Bompart, F. & Talbot, G. H. for the Synercid Emergency-Use Study Group. (1999). The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 44, 251-61.
6. Mackenzie, F. M., Greig, P., Morrison, D., Edwards, G. & Gould, I. M. (2002). Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. Journal of Antimicrobial Chemotherapy 50, 689-97.
7. Coia, J. E., Thomson-Carter, F., Baird, D. & Platt, D. J. (1990). Characterisation of methicillin-resistant Staphylococcus aureus by biotyping, immunoblotting and restriction enzyme fragmentation patterns. Journal of Medical Microbiology 31, 125-32.
8. Andrews, J. M., Ashby, J. P. & Wise, R. (1999). Study to assess the reliability of a disc diffusion method for determining the sensitivity of Gram-positive organisms to dalfopristin/quinupristin. Journal of Antimicrobial Chemotherapy 43, 141-3.
9. Seppala, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, 885-91.
10. Vannuffel, P. & Cocito, C. (1996). Mechanism of action of streptogramins and macrolides. Drugs 51, Suppl. 1, 20-30.